Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Mathematics reveals genetic pattern of tumor growth

Mathematics reveals genetic pattern of tumor growth

June 25, 2007

Using mathematical theory, UC Irvine scientists have shed light on one of cancer's most troubling puzzles - how cancer cells can alter their own genetic makeup to accelerate tumor growth. The discovery shows for the first time why this change occurs, providing insight into how cancerous tumors thrive and a potential foundation for future cancer treatments.

UCI mathematicians Natalia Komarova, Alexander Sadovsky and Frederic Wan looked at cancer from the point of view of a tumor and asked: What can a tumor do to optimize its own growth? They focused on the phenomenon of genetic instability, a common feature of cancer in which cells mutate at an abnormally fast rate. These mutations can cause cancer cells to grow, or they can cause the cells to die.




The scientists found that cancerous tumors grow best when they are very unstable in early stages of development and become stable in later stages. In other words, tumors thrive when cancerous cells mutate to speed up malignant transformation, and then stay that way by turning off the mutation rate.

The study appeared this week in the Royal Society journal Interface.

"Mathematical theory can help us understand cancer," said Komarova, associate professor of mathematics at UCI. "If we know what cancer is doing, we might be able to find ways to fight it."

Previous studies have observed this genetic pattern by using laboratory techniques, but the UCI research is the first to explain why the pattern leads to tumor growth. The occurrence of genetic instability is often debated by cancer scientists, some of whom believe that cancer feeds on this instability and others who believe it is a side-effect of the cancer itself.

To determine the pattern of genetic changes that leads to the most robust tumor growth, Komarova and her colleagues used a mathematical technique called optimal control theory in which they considered a tumor with set characteristics, then changed the cell mutation variable to see under which circumstances the tumor grew best.

"The mutation rate serves as the control knob. Then, we can calculate mathematically how long it takes a tumor with given parameters to reach a certain size," Komarova said. "We found that at early stages of tumor growth, instability is advantageous, and later on it becomes an impediment. This explains why many tumors exhibit a high level of instability at first, and become stable later in their development."

This research was supported by a Sloan Fellowship and grants from the National Institutes of Health.

The University of California, Irvine



Related Tumor Growth Current Events and Tumor Growth News Articles Tumor Growth Current Events and Tumor Growth News RSS Tumor Growth Current Events and Tumor Growth News RSS
Laser therapy can aggravate skin cancer
High irradiances of low-level laser therapy (LLLT) should not be used over melanomas.

Common pain relief medication may encourage cancer growth
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.

Cancers' Sweet Tooth May Be Weakness
The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered.

Researchers 'notch' a victory toward new kind of cancer drug
Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed.

New mechanism explains how the body prevents formation of blood vessels
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels.

CSHL study shows that some malignant tumors can be shut down after all
Oncologists have had their hands tied because more than half of all human cancers have mutations that disable a protein called p53.

Hundreds of genes distinguish patients likely to survive advanced melanoma
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs.

1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.

Early-stage, HER2-positive breast cancer patients at increased risk of recurrence
Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

Researchers use drug-radiation combo to eradicate lung cancer
Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.
More Tumor Growth Current Events and Tumor Growth News Articles
Cancer Immunotherapy: Immune Suppression and Tumor Growth

Cancer Immunotherapy: Immune Suppression and Tumor Growth
by George C. Prendergast (Editor), Elizabeth M. Jaffee (Editor)

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumoral immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers an indispensable overview of immune escape as a critical trait...

  No. 571(Tumors, Growths) 1 oz
by PROGRESSIVE LABS



Charlie Rose with Anthony Robbins (July 19, 2000)

Charlie Rose with Anthony Robbins (July 19, 2000)

Motivational speaker Anthony Robbins on his unusual career advising everyone from Andre Agassi and President Clinton to the IBM Corporation and the United States Army and the launch of his new website, www.dreamlife.com.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

Intracranial Tumor Canvas Print - Canvas Art

Intracranial Tumor Canvas Print - Canvas Art
by FineArtAmerica.com

This is a beautiful stretched-canvas art print wrapped on 2.5" thick stretcher bars. The print is professionally printed, assembled, and shipped within 2 - 3 business days from our production facility in North Carolina and arrives ready-to-hang on your wall. FineArtAmerica.com is home to more than 20,000 artists from all over the world who entrust us to fulfill their print orders online. We offer a 30-day money-back guarantee on every print that we sell and look forward to helping you select your next piece.

Olympian Labs Ip-6, Inositol Hexaphosphate

Olympian Labs Ip-6, Inositol Hexaphosphate
by Olympian Labs

Inositol hexaphosphate is a sugar molecule attached to six phosphate molecules. It is found throughout nature, in wheat and rice bran, legumes such as soybeans and virtually every kind of mammalian cell. It plays an important role in regulating vital cellular functions including cell proliferation and differentiation.

There has been research on human liver cancer cells that were treated with inositol hexaphosphate and transplanted into mice. They found that inositol hexaphosphate slowed or stopped the growth of liver cancer cells and shrank existing tumors three- to four-fold. Inositol hexaphosphate does not kill cancer cells - it tames them and makes them behave like normal cells. Inositol hexaphosphate decreases proliferation of cancer cells and causes them to differentiate,...

  History of HRT use benefits breast cancer patients. (Tumor Growth Reduced in Bone).(hormone replacement therapy): An article from: Family Practice News
by Bruce Jancin (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2003. The length of the article is 608 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: History of HRT use benefits breast cancer patients. (Tumor Growth Reduced in Bone).(hormone replacement therapy)
Author: Bruce Jancin
Publication: Family Practice News (Magazine/Journal)
Date: March 1, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 5 Page: 49(1)

Distributed by Thomson...

  Peregrine's phospholipid-targeted antibodies fused wth cytokines reduce tumor growth.: An article from: BIOTECH Patent News
by Gale Reference Team (Author)

This digital document is an article from BIOTECH Patent News, published by Thomson Gale on September 1, 2006. The length of the article is 654 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Peregrine's phospholipid-targeted antibodies fused wth cytokines reduce tumor growth.
Author: Gale Reference Team
Publication: BIOTECH Patent News (Newsletter)
Date: September 1, 2006
Publisher: Thomson Gale
Volume: 20 Issue: 9

Distributed by Thomson...

  Mechanism of tumor growth in crowngall
by Erwin F Smith (Author)



Growth Factors and Tumor Promotion: Implications for Risk Assessment

Growth Factors and Tumor Promotion: Implications for Risk Assessment
by Tex.) International Conference on Carcinogenesis and Risk Assessment (7th : 1993 : Austin (Author), Thomas J. Slaga (Editor), Robert Leboeuf (Editor), Henry Pitot (Editor), R. Michael McClain (Editor)

Hoffman LaRoche, Inc., Nutley, New Jersey. Proceedings of the Seventh International Conference on Carcinogenesis and Risk Assessment held December 1-4, 1993, in Austin, Texas.

  Influence of the Host on Tumor Development (Cancer Growth and Progression)
by Ronald B. Herberman (Editor)

X

© 2009 BrightSurf.com